Chronic Wounds - Epidemiology Forecast - 2036

Chronic Wounds Insights and Trends

• Chronic wounds are defined as wounds that fail to progress through the normal stages of healing within an expected timeframe (typically >4-6 weeks). They are commonly associated with underlying conditions such as Diabetes Mellitus, venous insufficiency, arterial disease, and prolonged pressure, leading to impaired tissue repair and persistent inflammation.
• Unlike acute wounds, chronic wounds are characterized by a dysregulated healing process, involving prolonged inflammation, reduced angiogenesis, impaired collagen synthesis, and increased susceptibility to infection. These factors collectively delay wound closure and increase the risk of complications.
• The major types of chronic wounds include diabetic foot ulcers, venous leg ulcers, arterial ulcers, and pressure ulcers, each with distinct etiologies but overlapping pathological mechanisms related to poor perfusion and tissue damage.
• The severity of chronic wounds varies widely depending on factors such as underlying comorbidities, vascular status, infection, and patient adherence. In severe cases, complications can include deep tissue infection, sepsis, and amputation, particularly in diabetic populations.
• Diagnosis of chronic wounds involves a comprehensive clinical assessment, including wound history, physical examination, evaluation of vascular supply (e.g., ankle-brachial index), and identification of infection. Additional tools such as imaging and microbiological testing may be used to assess underlying complications.
• Despite advancements in wound care, there remains a lack of reliable biomarkers and standardized diagnostic tools to accurately predict healing outcomes and guide personalized treatment strategies.
• Early identification and accurate assessment are critical for initiating appropriate interventions, preventing complications, and improving healing outcomes. Multidisciplinary management involving wound care specialists, vascular experts, and primary care providers plays a key role in optimizing patient care.

DelveInsight's 'Chronic Wounds - Epidemiology Forecast - 2036' report delivers an in-depth understanding of the chronic wounds, historical and forecasted epidemiology of the United States, EU4 (Germany, Spain, Italy, and France), and the United Kingdom, and Japan.

Chronic Wounds Understanding and Diagnosis Algorithm

Chronic Wounds Overview

Chronic wounds are defined as wounds with an inability to heal within an anticipated time frame. They are widespread and frequently mistreated. A wound is considered chronic or non-healing when it has not fully healed even after four to six weeks of screening. Venous ulcers (Vein ulcers, arterial ulcers), diabetic foot ulcers (DFU), and pressure ulcers are examples of common chronic wound types. While different etiologies of chronic wounds are associated with slightly different symptoms, the most common way to recognize a chronic wound is by its elevated, hyperproliferative, yet immobile wound edge. There will be inflammation in the vicinity of the wound, which could harm the healing process. Other common signs and symptom checklists include Bleeding, swelling, pain or blistering, darkened skin around the wound, difficulty moving the injured area, enlarged or deepened injury, fever, itching, milky pus, and warmth or heat when touched.

Chronic Wounds Diagnosis

The initial step in evaluating a wound clinically involves distinguishing between acute and chronic wounds. This is followed by a thorough physical examination, which includes assessing the wound's size, depth, location, and any indications of infection. Additionally, inspecting the surrounding skin and tissues for signs like inflammation, necrosis, or edema is crucial. Understanding the patient's medical history is also paramount, as conditions such as diabetes, peripheral vascular disease, immunosuppression, and prior wound healing complications can significantly impact healing. Consequently, documentation typically includes details such as the wound's location, size, depth, presence of drainage, and tissue type. By considering the wound's location and appearance, most chronic wounds can be categorized by their underlying cause, facilitating appropriate assessment.

Chronic Wounds Epidemiology

Key Findings from Chronic Wounds Epidemiological Analysis and Forecast

• As per DelveInsight analysis, in 2025, the total diagnosed prevalent cases of chronic wounds in the 7MM are estimated to be approximately 12 million cases.
• In 2025, the US accounted for approximately 7.1 million cases. Among these, pressure ulcers accounted for approximately 38%, diabetic foot ulcers for 35%, venous ulcers for 18%, and other types of chronic wounds for the remaining 9%.
• Among the EU4 and the UK, Germany accounted for the highest cases, i.e., nearly 1 million diagnosed prevalent cases of chronic wounds, followed by France and the UK. These cases are expected to rise by 2036 primarily due to the heightened focus on research and clinical trials for the disease.
• Among type-specific diagnosed prevalent cases of chronic wounds in Japan, pressure ulcers had the highest contribution of cases in 2025, with nearly 54% cases, followed by around 23%, 10%, and 10% cases for venous ulcers, diabetic foot ulcers, and others, respectively.

Scope of the Report:

• The report covers a segment of a descriptive overview of chronic wounds, explaining their causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

Chronic Wounds Patient Population Forecast

Report Key Strengths

• Epidemiology-based (Epi-based) bottom-up forecasting
• 11-year forecast
• Patient Burden trends (by geography)

FAQs:

• What are the disease risks, burdens, and unmet needs of chronic wounds? What will be the growth opportunities across the 7MM concerning the patient population with chronic wounds?
• What is the historical and forecasted chronic wounds patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy:

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders' perspectives on the diagnostic challenges to overcome barriers in the future.
• Detailed insights into various factors hampering disease diagnosis and other existing diagnostic challenges.